Cargando…
Anti-vascular endothelial growth factor in age-related macular degeneration: Puzzle or a silent beginning!
Autor principal: | Natarajan, Sundaram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831761/ https://www.ncbi.nlm.nih.gov/pubmed/24104704 http://dx.doi.org/10.4103/0301-4738.119421 |
Ejemplares similares
-
The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration
por: Azad, Rajvardhan, et al.
Publicado: (2007) -
Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage
por: Maruyama-Inoue, Maiko, et al.
Publicado: (2023) -
Macular Atrophy Development and Subretinal Drusenoid Deposits in Anti-Vascular Endothelial Growth Factor Treated Age-Related Macular Degeneration
por: Zarubina, Anna V., et al.
Publicado: (2017) -
Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration
por: Kim, Ramasamy
Publicado: (2007) -
Ten-year outcome of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
por: Upasani, Deepa, et al.
Publicado: (2021)